SENNA-S 50 mg/1
Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg · TABLET, COATED · HealthLife of USA LLC
SENNA-S is a tablet, coated containing senna and docusate sodium tablets, 8.6 mg and 50 mg at 50 mg/1, taken oral. Manufactured by HealthLife of USA LLC.
Key Facts
- Brand Name
- SENNA-S
- Generic Name
- Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg
- NDC Code (Product)
69517-131- Manufacturer
- HealthLife of USA LLC
- Strength
- 50 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- 505G(a)(3)
- Marketing Start
- 03/07/2016
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is SENNA-S used for?
SENNA-S contains Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is SENNA-S a controlled substance?
SENNA-S is not classified as a controlled substance by the DEA.
What is the generic name for SENNA-S?
The generic name for SENNA-S is Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg. There are no other listed brand versions of Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg.
What is the NDC code for SENNA-S 50 mg/1?
The NDC (National Drug Code) for SENNA-S 50 mg/1 is 69517-131, listed by HealthLife of USA LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)